Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China flag China · Delayed Price · Currency is CNY
29.55
-0.62 (-2.06%)
At close: Mar 9, 2026

SHA:688217 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-15.767.9340.4747.33
Depreciation & Amortization
43.3944.435.7337.52
Other Amortization
3.271.182.774.06
Loss (Gain) From Sale of Assets
-0.12-0.840.010.1
Asset Writedown & Restructuring Costs
16.677.6414.16-1.5
Loss (Gain) From Sale of Investments
-2.49-3.01-3.1-1.47
Provision & Write-off of Bad Debts
6.655.039.561.06
Other Operating Activities
-8.6-10.8721.64-5.28
Change in Accounts Receivable
14.49182.51-101.212.87
Change in Inventory
9.79-15.93-16.97-10.8
Change in Accounts Payable
2.86-167.2964.843.62
Change in Other Net Operating Assets
-4.12.158.84-
Operating Cash Flow
59.9845.173.0777.97
Operating Cash Flow Growth
33.00%-38.28%-6.28%11.20%
Capital Expenditures
-39.41-109.09-106.57-95.6
Sale of Property, Plant & Equipment
0.140.22-1.39
Investment in Securities
-21.983.56109.03-188.56
Other Investing Activities
1.992.744.584.19
Investing Cash Flow
-59.27-102.587.04-278.57
Long-Term Debt Issued
-201.35-
Total Debt Issued
-201.35-
Long-Term Debt Repaid
-23.08-7.22-5.87-4.62
Total Debt Repaid
-23.08-7.22-5.87-4.62
Net Debt Issued (Repaid)
-23.0812.78-4.52-4.62
Issuance of Common Stock
-8.97-224.04
Common Dividends Paid
-0.62-10.4-0.01-0.02
Other Financing Activities
----27.59
Financing Cash Flow
-23.711.36-4.53191.8
Foreign Exchange Rate Adjustments
0.660.844.69-1.54
Net Cash Flow
-22.33-45.2980.26-10.35
Free Cash Flow
20.57-64-33.5-17.63
Free Cash Flow Margin
8.49%-24.79%-7.90%-6.06%
Free Cash Flow Per Share
0.36-1.13-0.60-0.35
Cash Income Tax Paid
9.9917.591.16-1.81
Levered Free Cash Flow
25.32-63.29-58.2-31.58
Unlevered Free Cash Flow
25.87-62.77-57.86-31.28
Change in Working Capital
16.98-6.36-48.18-3.86
Source: S&P Global Market Intelligence. Standard template. Financial Sources.